Anna H. Owings, DO
House Officer
Department:
SOM-Medicine-DIG DIS
Email:
aowings@umc.edu
Work Phone:
(601) 984-5891
Education
| University of Alabama, BS, Biology |
Current Positions
| Assistant Professor, School of Medicine, Department of Medicine | 07/2025 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Publications
Letter | |
| Owings AH, Glover SC, Cheifetz AS, Papamichael K, Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease. Digestive diseases and sciences, 2025 Mar;70(3):1248-1249 | 2025 |
| Liu JJ, Owings AH, Claggett B, Robinson T, Glover SC, Response to Cheng et al. The American journal of gastroenterology, 2021 Dec 1;116(12):2474-2475 | 2021 |
Journal Article | |
| Bala N, Habib AH, Kozuch M, Denslow ND, Dhaliwal NS, Owings AH, Glover SC, Alli AA, Fatty Acids and Inflammatory Protein Biomarkers From Coronavirus Disease 2019 Patients. Immunity, inflammation and disease, 2025 Jul;13(7):e70218 | 2025 |
| Tomalka JA, Owings A, Galeas-Pena M, Ziegler CGK, Robinson TO, Wichman TG, Laird H, Williams HB, Ghaliwal NS, Everman S, Zafar Y, Walsh JML, Shalek AK, Horwitz BH, Ordovas-Montanes J, Glover SC, Gibert Y, Enhanced Production of Lipid Mediators in Plasma and Activation of DNA Damage Pathways in PBMCs Are Correlated With the Severity of Ancestral SARS-CoV-2 Infection. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025 May 15;39(9):e70600 | 2025 |
| Aziz S, Hamid A, Shaikh A, Mansoor R, Owings A, Unveiling Disparities in Heart Failure and Cirrhosis Related Mortality: CDC WONDER 1999 to 2020. Digestive diseases and sciences, 2025 Jun;70(6):2128-2137 | 2025 |
| Walsh JML, Miao VN, Owings AH, Tang Y, Bromley JD, Kazer SW, Kimler K, Asare C, Ziegler CGK, Ibrahim S, Jivanjee T, George M, Navia AW, Drake RS, Parker A, Billingsley BC, Dotherow P, Tarugu S, Kota SK, Laird H, Wichman TG, Davis YT, Dhaliwal NS, Pride Y, Guo Y, Senitko M, Harvey J, Bates JT, Diamond G, Garrett MR, Robinson DA, Frame IJ, Lyons JJ, Robinson TO, Shalek AK, Horwitz BH, Glover SC, Ordovas-Montanes J, Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2. Nature immunology, 2025 Feb;26(2):294-307 | 2025 |
| Aziz S, Akhlaq A, Owings A, Gurz S, Zafar Y, Ali B, Tang SJ, Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020. Inflammatory bowel diseases, 2025 Jun 13;31(6):1574-1582 | 2025 |
| Diamond G, Figgins EL, Gao D, Robinson TO, Wilson K, Gabbard JD, Anderson CD, Batra L, Sreenivasan C, Zheng J, Do U, Mulcahy B, Ryan LK, McLaughlin N, Owings AH, Dhaliwal N, Williams HB, Wichman TG, Galeas-Pena M, Glover SC, Regulation of Paneth cell-specific genes in COVID-19 patients and SARS-CoV-2-infected mice by quantification of mRNA from exfoliated cells in stool samples. Scientific reports, 2024 Dec 30;14(1):31740 | 2024 |
| Abadir A, Troia A, Said H, Tarugu S, Billingsley BC, Sairam N, Minchenberg SB, Owings AH, Parker AM, Brousse B, Carlyle A, Owens BR, Hosseini-Carroll P, Galeas-Pena M, Frasca J, Glover SC, Papamichael K, Cheifetz AS, Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease. Digestive diseases and sciences, 2024 Aug;69(8):2796-2803 | 2024 |
| Ziegler CGK, Owings AH, Galeas-Pena M, Kazer SW, Miao VN, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Pride Y, Abraham GE 3rd, Senitko M, Robinson TO, Diamond G, Lionakis MS, Shalek AK, Ordovas-Montanes J, Horwitz BH, Glover SC, An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection. Microbiology spectrum, 2024 Jun 4;12(6):e0351623 | 2024 |
| Tomalka JA, Owings A, Galeas-Pena M, Ziegler CGK, Robinson TO, Wichman TG, Laird H, Williams HB, Dhaliwal NS, Everman S, Zafar Y, Shalek AK, Horwitz BH, Ordovas-Montanes J, Glover SC, Gibert Y, Enhanced production of eicosanoids in plasma and activation of DNA damage pathways in PBMCs are correlated with the severity of ancestral COVID-19 infection. medRxiv : the preprint server for health sciences, 2023 Sep 15; | 2023 |
| Burstiner LS, Owings AH, Tacy C, Perez M, Royer A, Hreish Y, Johnson J, Barr M, Laird H, Tarugu S, Robinson TO, Hosseini-Carroll P, Liu J, Glover SC, A focused retrospective study on differences in IBD characteristics between Black and White patients in the south. The American journal of the medical sciences, 2023 Jun;365(6):488-495 | 2023 |
| Burstiner LS, Owings AH, Royer A, Hreish Y, Johnson J, Barr M, Laird H, Tarugu S, Edwards K, Bradley L, Brar H, Robinson TO, Hosseini-Carroll P, Liu J, Glover SC, Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients. Inflammatory bowel diseases, 2023 Dec 5;29(12):1847-1853 | 2023 |
| Darwish S, Liu LP, Robinson TO, Tarugu S, Owings AH, Glover SC, Alli AA, COVID-19 Plasma Extracellular Vesicles Increase the Density of Lipid Rafts in Human Small Airway Epithelial Cells. International journal of molecular sciences, 2023 Jan 14;24(2) | 2023 |
| Ziegler CGK, Owings AH, Miao VN, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Pride Y, Abraham GE 3rd, Senitko M, Robinson TO, Lionakis MS, Shalek AK, Ordovas-Montanes J, Horwitz BH, Glover SC, Severe COVID-19 is associated with fungal colonization of the nasopharynx and potent induction of IL-17 responses in the nasal epithelium. medRxiv : the preprint server for health sciences, 2022 Oct 26; | 2022 |
| Herbert J, Teeter E, Burstiner LS, Doka R, Royer A, Owings AH, Liu J, Glover SC, Hosseini-Carroll P, Urinary manifestations in African American and Caucasian inflammatory bowel disease patients: a retrospective cohort study. BMC urology, 2022 Jan 4;22(1):1 | 2022 |
| Diamond G, Figgins EL, Robinson T, Senitko M, Abraham GE, Williams HB, Sloan M, Owings A, Laird H, Pride Y, Wilson KJ, Hasan M, Parker A, Glover SC, Examination of gene expression in saliva samples from COVID-19 patients to study the host defense response against SARS-CoV-2 in the oral cavity. Molecular oral microbiology, 2021 Apr;36(2):157-158 | 2021 |
| Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE 3rd, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J, Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell, 2021 Sep 2;184(18):4713-4733.e22 | 2021 |
| Liu JJ, Sloan ME, Owings AH, Figgins E, Gauthier J, Gharaibeh R, Robinson T, Williams H, Sindel CB, Backus F, Ayyalasomayajula K, Parker A, Senitko M, Abraham GE 3rd, Claggett B, Horwitz BH, Jobin C, Adelman RM, Diamond G, Glover SC, Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy. The American journal of gastroenterology, 2021 Aug 1;116(8):1638-1645 | 2021 |
| Konnikova L, Robinson TO, Owings AH, Shirley JF, Davis E, Tang Y, Wall S, Li J, Hasan MH, Gharaibeh RZ, Mendoza Alvarez LB, Ryan LK, Doty A, Chovanec JF, O'Connell MP, Grunes DE, Daley WP, Mayer E, Chang L, Liu J, Snapper SB, Milner JD, Glover SC, Lyons JJ, Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia. The Journal of allergy and clinical immunology, 2021 Sep;148(3):813-821.e7 | 2021 |
| Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE 3rd, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J, Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. bioRxiv : the preprint server for biology, 2021 Feb 20; | 2021 |
| Burstiner LS, Silver J, Burstiner LJ, Teymoorian A, Pallav K, Jones D, Owings A, Glover S, Escherichia coli O157: H7 sepsis following fecal microbiota transplant in an IgA-deficient inflammatory bowel disease patient. Gastroenterology report, 2022;10:goab041 | |
| Newsome RC, Gauthier J, Hernandez MC, Abraham GE, Robinson TO, Williams HB, Sloan M, Owings A, Laird H, Christian T, Pride Y, Wilson KJ, Hasan M, Parker A, Senitko M, Glover SC, Gharaibeh RZ, Jobin C, The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut microbes, 2021 Jan-Dec;13(1):1-15 | |